Illumina Appoints Everett Cunningham As Chief Commercial Officer
06/03/24, 11:29 AM
Position
chief commercial officer
Illumina, Inc. announced the appointment of Everett Cunningham as Chief Commercial Officer, effective June 10. Cunningham will be responsible for building, guiding, and managing the company's global commercial organization, bringing extensive commercial experience across the healthcare tech, life sciences, and pharmaceutical industries.
Company Info
Additional Info
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit www.illumina.com and connect with us on Twitter, Facebook, LinkedIn, Instagram, and YouTube.
Investors:Brian Blanchett858.291.6421 IR@illumina.com
Media:Dr. Karen Birmingham646.355.2111 pr@illumina.com